吉林长龙药业:一个类似巴菲特联合电车公司的投资,港股隐身的存在

新浪财经
14 Nov 2024

“缘起”研究 中药 行业,看到同名同方的IND数量和获批数量,有感发于雪球一则讨论:“尿毒清的底气,同名同方申请的少,获批的更少,仅有佐力的百令胶囊获批,而且佐力本身做百令片,算是有底子,看来即使专利过期,中药的的仿制也不是那么容易,给了企业回旋应对的空间。”球友回复,和海昆肾喜胶囊对比怎么样?原来仅知道,海昆肾喜12年降价11%+,尿毒清提价11%+,顺便就继续查了一下,结果发现了这家公司: ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10